Narayana Hrudayalaya Limited (NSE:NH)
India · Delayed Price · Currency is INR 1,734.90
-24.90 (-1.41%)
Oct 24, 2025, 3:30 PM IST
Narayana Hrudayalaya Revenue
Narayana Hrudayalaya had revenue of 15.07B INR in the quarter ending June 30, 2025, with 12.40% growth. This brings the company's revenue in the last twelve months to 56.84B, up 10.89% year-over-year. In the fiscal year ending March 31, 2025, Narayana Hrudayalaya had annual revenue of 54.83B with 12.12% growth.
Revenue (ttm)
56.84B
Revenue Growth
+10.89%
P/S Ratio
6.20
Revenue / Employee
4.98M
Employees
11,411
Market Cap
352.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 54.83B | 5.93B | 12.12% |
| Mar 31, 2024 | 48.90B | 3.61B | 7.96% |
| Mar 31, 2023 | 45.30B | 8.28B | 22.38% |
| Mar 31, 2022 | 37.01B | 11.17B | 43.24% |
| Mar 31, 2021 | 25.84B | -5.53B | -17.62% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |
Narayana Hrudayalaya News
- 5 weeks ago - Narayana Hrudayalaya invests USD 2.5 million in Cayman Integrated Healthcare - Business Upturn
- 5 months ago - HSBC maintains reduce on Narayana Hrudayalaya, sees long gestation for India expansion - Business Upturn
- 5 months ago - Narayana Hrudayalaya shares rise nearly 4% after Q4 profit and revenue growth; stock nears 52-week high - Business Upturn
- 7 months ago - Narayana Hrudayalaya signs O&M agreement with Kammavari Sangham for 110-bed hospital in Bengaluru South - Business Upturn
- 8 months ago - Narayana Hrudayalaya’s subsidiary HCCI enters joint venture for cancer care in India - Business Upturn
- 8 months ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 8 months ago - Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
- 9 months ago - Key Results Today: Glenmark Pharma, ABFRL, GNFC, and Narayana Hrudayalaya among stocks in focus as Q3 results roll in - Business Upturn